Previous Close | 72.87 |
1-Year Change | 176.97% |
6-Months Change | 174.15% |
3-Months Change | 12.61% |
Moving Avg (50d) | 74.703 |
Moving Avg (200d) | 44.322 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 10.4B |
Beta (3-Years) | 1.09 |
Revenue Growth (ttm) | 15.95% |
Net Profit Margin (ttm) | -257.69% |
Return On Assets (ttm) | -54.62% |
EPS (ttm) | -5.29 |
PE Ratio (ttm) | -13.78 |
Dividend Yield | % |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Biotechnology |
Country: | United States |